Pediatric Neuromuscular Center, Department of Pediatrics, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland.
Eur J Paediatr Neurol. 2011 Jan;15(1):40-7. doi: 10.1016/j.ejpn.2010.07.002. Epub 2010 Aug 17.
Multiple motor function and strength assessment tools exist for the evaluation of neuromuscular diseases, but most do not directly assess functional ability in the patients' daily physical activity in their home environment. In this study our aim was to assess: 1) the feasibility and accuracy of physical activity monitoring during two days in a home environment of five DMD patients using a non-commercialized monitor containing a 3D accelerometer and a gyroscope, 2) if a difference in the physical activity parameters could be measured before and one month after starting prednisolone. We reliably quantified the time spend sitting, standing, lying, walking, the number of steps taken, the cadence, the number of walking episodes and their duration as well as how these were distributed over the day. Parameters possibly reflecting endurance, such as the duration of the walking episodes or the succession of two or three walking episodes lasting more than 30 s were the most improved after prednisolone treatment. This degree of detailed determination of physical activity in a home environment has not been previously reported in neuromuscular disorders to our knowledge and some of the reported parameters are potential new outcome measures in clinical trials.
有多种用于评估神经肌肉疾病的运动功能和力量评估工具,但大多数工具并不能直接评估患者在日常生活活动中的功能能力。在这项研究中,我们旨在评估:1)使用包含 3D 加速度计和陀螺仪的非商业化监测仪,在 5 名 DMD 患者的家庭环境中监测两天的日常活动的可行性和准确性,2)在开始泼尼松龙治疗之前和一个月后,是否可以测量出运动参数的差异。我们可靠地量化了患者在坐姿、站立、躺卧、行走状态下的时间、步数、步频、行走次数及其持续时间,以及这些活动在一天中的分布情况。一些可能反映耐力的参数,如行走持续时间或持续超过 30 秒的两个或三个行走序列的连续发生,在泼尼松龙治疗后改善最明显。据我们所知,在神经肌肉疾病中,以前没有在家居环境中如此详细地确定运动活动,其中一些报告的参数可能是临床试验中的新的潜在疗效指标。